Data Demonstrate Efficacy, Safety With ORENCIA In Adults With Rheumatoid Arthritis

Bristol-Myers Squibb Company announced that cumulative data from a trial demonstrate the long-term efficacy and safety of ORENCIA in adult rheumatoid arthritis patients.

Leave a Reply

You must be logged in to post a comment.